ArticleRevista panamericana de salud publica = Pan American journal of public health2024
[High-quality Follow-up Measles and Rubella vaccination Campaign in Mexico, 2021Campanha de vacinação de seguimento de alta qualidade contra sarampo e rubéola no México, 2021].
Article in Revista panamericana de salud publica = Pan American journal of public health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To describe Mexico's experience of a high-quality follow-up vaccination campaign against measles and rubella in children aged 1 to 4 years, and actions taken to recover the coverage of other biologics during the COVID-19 health emergency. Method: Use of a microplanning tool in the design and implementation of a follow-up campaign to protect 8 604 781 girls and boys aged 1 to 4 years and to complete other vaccination schedules, followed by the implementation of rapid vaccination monitoring. Results: A total of 8 026 184 doses of MR vaccine were administered to children aged 1 to 4 years, with a coverage rate of 93.3%. In addition, 3 058 201 doses of MMR vaccine and 2 361 021 doses of hexavalent vaccine were administered. Rapid vaccination monitoring was carried out 78 times in selected municipalities in the country, where 30% (18 692) of 62 308 children aged 1-4 years contacted were found to be unvaccinated. The reasons for not vaccinating were "not knowing it was necessary" (28.5%), "not having time" (21.2%), "other reasons" (mainly fear of getting sick from COVID-19 in health centers) (12.9%), "believing they had received two doses of MMR vaccine" (9.1%), or "not knowing where to get vaccinated" (8.7%); 19.6% did not respond. Conclusions: The high-quality vaccination campaign was successful, favoring the sustainability of measles, rubella, and polio elimination, as well as the control of other vaccine-preventable diseases, and demonstrating the relevance of microplanning.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.